Sandra Lopez Miller is a Seguin, Texas based nurse practitioner. Active license number of Sandra Lopez Miller is 1140066 in Texas. Her current practice location is 3415 Old Spanish Trl, Seguin. Patients can reach her at 830-491-7907. Sandra Lopez Miller is FNP-C and her NPI number (Unique professional ID assigned by NPPES) is 1346022597. Sandra Lopez Miller has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Sandra Lopez Miller speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1346022597
NPI Enumeration Date:
20 Oct, 2023
NPI Last Update On:
21 Oct, 2023
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Sandra Lopez Miller are as mentioned below.
License Number
Specialization
State
Status
1140066
Texas
Primary
880673
Registered Nurse
Texas
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Sandra Lopez Miller 3415 Old Spanish Trl, Seguin, Texas
Zip:
78155-7307
Phone Number:
830-491-7907
Patients can reach Sandra Lopez Miller at 3415 Old Spanish Trl, Seguin, Texas or can call to book an appointment on 830-491-7907.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.